Northern Trust
BHVN

Northern Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Northern Trust’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-572,845
Closed -$86.6M – 4800
2022
Q3 		$86.6M Sell
572,845
-1,925
-0.3% -$285K 0.02% 594
2022
Q2 		$83.7M Buy
574,770
+48,218
+9% +$6.16M 0.02% 622
2022
Q1 		$62.4M Sell
526,552
-54,922
-9% -$6.85M 0.01% 881
2021
Q4 		$80.1M Buy
581,474
+25,281
+5% +$3.21M 0.01% 778
2021
Q3 		$77.3M Sell
556,193
-3,672
-0.7% -$458K 0.01% 795
2021
Q2 		$54.4M Buy
559,865
+19,323
+4% +$1.57M 0.01% 1066
2021
Q1 		$36.9M Sell
540,542
-18,432
-3% -$1.49M 0.01% 1361
2020
Q4 		$47.9M Sell
558,974
-12,145
-2% -$1.03M 0.01% 1107
2020
Q3 		$37.1M Sell
571,119
-15,497
-3% -$1.02M 0.01% 1119
2020
Q2 		$42.9M Buy
586,616
+61,824
+12% +$3.29M 0.01% 1006
2020
Q1 		$17.9M Buy
524,792
+49,949
+11% +$2.28M 0.01% 1485
2019
Q4 		$25.9M Sell
474,843
-15,006
-3% -$743K 0.01% 1525
2019
Q3 		$20.4M Buy
489,849
+91,128
+23% +$3.85M ﹤0.01% 1679
2019
Q2 		$17.5M Buy
398,721
+13,613
+4% +$767K ﹤0.01% 1782
2019
Q1 		$19.8M Buy
385,108
+39,475
+11% +$1.71M ﹤0.01% 1698
2018
Q4 		$12.8M Sell
345,633
-636
-0.2% -$22.9K ﹤0.01% 1904
2018
Q3 		$13M Buy
346,269
+22,346
+7% +$822K ﹤0.01% 2093
2018
Q2 		$12.8M Buy
323,923
+20,093
+7% +$638K ﹤0.01% 2105
2018
Q1 		$7.83M Buy
303,830
+186,274
+158% +$5.57M ﹤0.01% 2326
2017
Q4 		$3.17M Buy
117,556
+148
+0.1% +$4.08K ﹤0.01% 2872
2017
Q3 		$4.39M Buy
117,408
+4,381
+4% +$133K ﹤0.01% 2706
2017
Q2 		$2.83M Buy
+113,027
New +$2.6M ﹤0.01% 2953

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Northern Trust's BHVN Position: Q4 2022 in Review

Northern Trust sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 572,845 shares — an estimated $86.6M sold.

Northern Trust first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $86.6M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Northern Trust reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Northern Trust sold 572,845 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $86.6M.
  • Northern Trust first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Northern Trust's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $86.6M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.